EUVIMEDEUVIMED entdecken
Open Access

Genetic inhibitors of APOBEC3B-induced mutagenesis

Tony M Mertz, Elizabeth Rice-Reynolds, Ly Nguyen, Anna Wood, Cameron Cordero, Nicholas Bray, Victoria Harcy, Rudri K Vyas, Debra Mitchell, Kirill Lobachev, Steven A Roberts

Genome Research · 2023

DOI: 10.1101/gr.277430.122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genome Research, 2023. Verfasst von Tony M Mertz und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, Washington 99164, USA; tony.mertz@wsu.edu …. Hauptthemen laut MEDLINE: BRCA1 Protein, Breast Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cytidine deaminases APOBEC3A (A3A) and APOBEC3B (A3B) are prominent mutators of human cancer genomes. However, tumor-specific genetic modulators of APOBEC-induced mutagenesis are poorly defined. Here, we used a screen to identify 61 gene deletions that increase A3B-induced mutations in yeast. We also determined whether each deletion was epistatic with Ung1 loss, which indicated whether the encoded factors participate in the homologous recombination (HR)–dependent bypass of A3B/Ung1-dependent abasic sites or suppress A3B-catalyzed deamination by protecting against aberrant formation of single-stranded DNA (ssDNA). We found that the mutation spectra of A3B-induced mutations revealed genotype-specific patterns of strand-specific ssDNA formation and nucleotide incorporation across APOBEC-induced lesions. Combining these three metrics, we were able to establish a multifactorial signature of APOBEC-induced mutations specific to (1) failure to remove H3K56 acetylation, (2) defective CTF18–RFC complex function, and (3) defective HR-mediated bypass of APOBEC-induced lesions. We extended these results by analyzing mutation data for human tumors and found BRCA1/2-deficient breast cancers display three- to fourfold more APOBEC-induced mutations. Mirroring our results in yeast, Rev1-mediated C-to-G substitutions are mainly responsible for increased APOBEC-signature mutations in BRCA1/2-deficient tumors, and these mutations associate with lagging strand synthesis during replication. These results identify important factors that influence DNA replication dynamics and likely the abundance of APOBEC-induced mutation during tumor progression. They also highlight a novel role for BRCA1/2 during HR-dependent lesion bypass of APOBEC-induced lesions during cancer cell replication.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA1 ProteinBreast NeoplasmsHumansFemaleSaccharomyces cerevisiaeBRCA2 ProteinMutagenesisMutationCytidine DeaminaseMinor Histocompatibility AntigensProteins

Substanzen

BRCA1 ProteinBRCA2 ProteinCytidine DeaminaseMinor Histocompatibility AntigensAPOBEC3A protein, humanProteinsBRCA1 protein, humanBRCA2 protein, humanAPOBEC3B protein, human

Autor:innen und Institutionen

  • School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, Washington 99164, USA; tony.mertz@wsu.edu steven.roberts2@wsu.edu srober23@uvm.edu.
  • Department of Microbiology and Molecular Genetics, University of Vermont Cancer Center, University of Vermont, Burlington, Vermont 05405, USA.
  • School of Molecular Biosciences and Center for Reproductive Biology, Washington State University, Pullman, Washington 99164, USA.
  • School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.

Förderung

  • NIEHS NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health
  • National Institute of Environmental Health Sciences
  • National Cancer Institute
  • Breast Cancer Research
  • Department of Defense

Zitieren

APA

Mertz, T. M., Rice-Reynolds, E., Nguyen, L., Wood, A., Cordero, C., Bray, N., Harcy, V., Vyas, R. K., Mitchell, D., Lobachev, K., & Roberts, S. A. (2023). Genetic inhibitors of APOBEC3B-induced mutagenesis. Genome Research. https://doi.org/10.1101/gr.277430.122

Vancouver

Mertz TM, Rice-Reynolds E, Nguyen L, Wood A, Cordero C, Bray N, et al. Genetic inhibitors of APOBEC3B-induced mutagenesis. Genome Research. 2023. doi:10.1101/gr.277430.122

BibTeX
@article{Mertz2023,
  author = {Mertz, Tony M and Rice-Reynolds, Elizabeth and Nguyen, Ly and Wood, Anna and Cordero, Cameron and Bray, Nicholas and Harcy, Victoria and Vyas, Rudri K and Mitchell, Debra and Lobachev, Kirill and Roberts, Steven A},
  title = {Genetic inhibitors of APOBEC3B-induced mutagenesis},
  journal = {Genome Research},
  year = {2023},
  doi = {10.1101/gr.277430.122}
}
Kostenlos starten →